Jobs / United States / Medtronic INC
Director - Clinical Research - Peripheral Nerve Stimulation - (On-site) - Cleveland, Ohio or Minneapolis, MN
Medtronic INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 193 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 106 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Medtronic INC paid sponsored hires in similar roles1 certified filing for “Clinical Manager” (Computer and Information Systems Managers) in FL: $127k–$127k, median $127k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Medtronic INC
The US Department of Labor certified 193 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 106 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Medtronic INC →
About the role
We anticipate the application window for this opening will close on - 20 Oct 2026 Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact. A Day in the Life The Neuromodulation portfolio develops therapies that address chronic pain and improve patient outcomes through targeted neurostimulation technologies. Within this portfolio, the Peripheral Nerve Stimulation (PNS) business is focused on generating clinical and economic evidence that supports regulatory approvals, reimbursement, therapy adoption, and expansion into new indications globally. This leadership role partners across Clinical Research, Research & Development, Medical Science, Regulatory, Marketing, Health Economics, and Commercial teams to advance the clinical evidence strategy and execution for PNS therapies. The position reports to the Vice President, Clinical Research and Medical Science, Neuromodulation and Pain Therapies. This position may be based in Minneapolis, Minnesota or Cleveland, Ohio and follows an onsite work model with an expectation of four days per week in the office. Travel is expected up to 10-25%%. The Clinical Research Director for Neuromodulation Peripheral Nerve Stimulation (PNS) Therapies, provides strategic and operational leadership for global clinical evidence generation across the product lifecycle. This role leads the development and execution of pre-market and post-market clinical research programs, translates evidence into stakeholder value, and drives publication and dissemination strategies that support regulatory, reimbursement, and commercial objectives. Primary Responsibilities • Lead the global clinical evidence strategy for Peripheral Nerve Stimulation therapies across the product lifecycle. • Define evidence requirements that address customer, regulatory, payer, and market access needs. • Direct the design, execution, and oversight of pre-market and post-market clinical studies. • Ensure clinical research programs meet scientific, ethical, quality, and regulatory standards worldwide. • Partner with cross-functional stakeholders to align clinical evidence strategies with business, research and development, regulatory, and commercial objectives. • Drive evidence-generation activities including clinical trials, retrospective database analyses, and meta-analyses. • Lead publication and dissemination strategies through peer-reviewed manuscripts, congress presentations, and scientific forums. • Provide leadership to internal teams, external investigators, advisors, and research partners to achieve study and evidence-generation objectives. Required Qualifications • Bachelor's degree with 10+ years of clinical research, medical affairs, clinical strategy, or related healthcare industry experience and 7+ years of people leadership experience OR Master's degree, Doctor of Philosophy (PhD), or Doctor of Pharmacy (PharmD) with 8+ years of clinical research, medical affairs, clinical strategy, or related healthcare industry experience and 7+ years of people leadership experience. • Experience leading global clinical research programs across pre-market and post-market studies. • Experience developing and executing clinical evidence strategies that support regulatory, reimbursement, and commercial objectives. • Knowledge of clinical research regulations, Good Clinical Practice (GCP), and global clinical